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Sixteen percent of the myocardium is composed of capillary, including lumen and endothelium (18) . The endothelium supplies oxygen and is also responsible for the generation of nitric oxide (NO) for relaxation of underlying cardiac muscle. The increase in pulse pressure during chronic volume overload may develop protracted cycles of ischemia-reperfusion (6, 37) . The high oxygen concentration produces oxyradical: 2O 2 ϩ 2H 2 O ϭ 2H 2 O 2 ϩ O 2 Ϫ (toxic oxygen), dependent or independent of NADH/NAD oxidase (4) , and masks the activity of superoxide dismutase and catalase (25, 28, 41) . The production of oxyradical (O 2 Ϫ ⅐) is transient. However, superoxide, O 2 Ϫ , and H 2 O 2 (2OH Ϫ ) are stable in the plasma as well as tissue. In volume overload, the capillary endothelial cell density is decreased (2, 29) . The collagen content is decreased or near normal (29, 42) . The mechanism of decreased endothelium and increased collagenolysis in chronic volume overload is unclear. Oxyradical species stimulate MMPs (39, 46, 58) , and in vivo inhibition of NO production by N-nitro-L-arginine methyl ester increases MMP activity (38) . In culture conditions, inhibition of cytokine-induced NO synthase reduced both expression and activity of MMPs (43) . In contrast, cytokine-inducible MMPs in immortalized cells were not modified by NO synthase inhibition (19) . The reasons for such diverse effects of NO on MMPs are not clear. However, a differential regulation of MMP release and activation in vivo versus in vitro may account for this discrepancy. The inhibition of NO production as well as the degradation of the ECM facilitate apoptosis (36, 48, 63) . Oxidative stress instigates the decrease in endothelial NO availability (10, 65) as well as increases the levels of cytokines, growth factors, and neurohormones (11, 17, 26) . This may further increase oxidative stress in which neurohormones such as angiotensin II (56) increase oxidative stress by decreasing the levels of bradykinin and prostaglandins; these molecules, otherwise, mediate antioxidation by increasing NO production (61) . In parallel, angiotensin II also induces NADH/NAD oxidase (64) . We hypothesized that the volume overload increases oxidative stress, leading to activate latent resident myocardial MMP. This causes collagenolysis, induces apoptosis, and impairs capillary endothelium and endocardium.
MATERIALS AND METHODS
Animal protocol. Male Sprague-Dawley rats, 275-300 g, were obtained from Harlan Laboratories. Several models of volume overload, such as the conversion of pressure overload to volume overload by minoxidil and other drugs, have been used (51) . Besides vasodilation, minoxidil also has a central effect (50) . Also, creation of volume overload by mitral valve regurgitation secondary to chordal rupture (34) generates myocardial injury. On the other hand, an infrarenal arteriovenous (A-V) fistula creates an unambiguous model of chronic volume overload. In this model, arterial blood, below the kidneys, rapidly enters into the venous circulation and overloads the ventricle without contribution of the stimulation of circulating factors (16) . To create an A-V fistula, rats were anesthetized with pentobarbital (50 mg/kg ip). A midline incision was performed to create the A-V fistula (16) . The caudal vena cava ϳ1.5 cm below the renal arteries was identified. Blunt dissection was used to remove the overlying adventitia and expose the vessels, taking care not to disrupt the tissue connecting the vessels. Both vessels were then occluded proximal and distal to the intended puncture site, and an 18-gauge needle was inserted into the exposed abdominal aorta and advanced through the medial wall into the vena cava to create the fistula. The needle was withdrawn, and the ventral aortic puncture was sealed with cyanoacrylate. Creation of a successful A-V fistula was visually evident by the pulsatile flow of oxygenated blood into the vena cava.
The abdominal musculature and skin incisions were closed in layers by standard techniques with absorbable suture and autoclips. The rats were kept warm and were monitored for any sign of morbidity for 2 h postsurgery before transport to the animal care unit. Sham rats were treated similarly except no punch was made. Rats were divided into the following experimental groups: 1) A-V fistula rats treated with nicotinamide (Nic; 0.67 mg/ml) in drinking water (A-V fistula ϩ Nic), 2) sham-operated rats treated with Nic (sham ϩ Nic), 3) A-V fistula rats, 4) sham operated (sham), and 5) control; n ϭ 6 rats/group. To avoid early effect of oxidative stress, the Nic intervention, which began 2 days before A-V fistula or sham surgery, also continued for the entire duration of the experiment in these rats. This dose of Nic was based on the fact that the rat drink ϳ25 ml/day and ingests ϳ17 mg/day, and this concentration was enough to saturate all the binding sites on NADH/NAD oxidase (13) as well as poly(ADP-ribose) synthetase, an enzyme that can be activated by peroxynitrite and oxidants (7, 12) , the two major pathways of oxyradical formation and apoptosis. All rats were exposed to a similar environment. Animal room temperature was maintained between 22 and 24°C. A 12:12-h light-dark cycle was maintained by artificial illumination. All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center, Jackson, MI. All rats were given rat chow (deficient of niacin) and water ad libitum. Levels of water, food intake, and changes in body weight were measured every other day.
The rats were anesthetized with Inactin (100 mg/kg ip) at 4 wk. This anesthesia has minimal effect on cardiovascular function (9) . To measure arterial pressure, a fluid-filled arterial catheter (polyethylene-50) was inserted into the left femoral artery. For the measurements of end-diastolic pressure (EDP), another catheter was advanced into the left ventricle (LV) through the right common carotid artery and aorta. The catheters were connected to pressure transducers (Micro-Med) positioned at the level of the heart. Ten minutes after the insertion of catheters, arterial pressure, heart rate, systolic and diastolic blood pressure (SBP and DBP, respectively), and EDP were recorded (32) . The hearts were weighed. Because heart tissue was used for protein and mRNA isolation, the tissue was dissected under sterilized conditions. A portion of the LV was fixed in 10% zinc formalin for histology, immunostaining, and TdT-mediated dUTP nick-end labeling (TUNEL). For mRNA analysis, the tissue was processed within 10 min after death or frozen in liquid nitrogen before use. Total RNA was isolated using RNAZol solution. For the analysis of malondialdehyde (MDA) and NO, the tissue was homogenized in 10 mM Tris-Cl (pH 7.4); for nitrotyrosine, MMP, TIMP, and collagen degradation peptides, the LV tissue homogenate was prepared as previously described (55, 59 ). The total protein was measured by Bio-Rad dye-binding assay.
Malondialdehyde. Biomarkers of oxidative stress such as isoprostane have been used in coronary artery disease (27) , and MDA is used in chronic heart failure (14) . Therefore, MDA and thiobarbituric acid-reactive species (TBARS) were measured by reacting the LV tissue homogenates prepared from control, sham, sham ϩ Nic, A-V fistula, and A-V fistula ϩ Nic rats. The fluorescence at 560 nm was measured when excited at 525 nm (24) . 1,1,3,3-Tetraethoxypropane (Sigma) was used as a standard. The concentrations of TBARS in samples were measured by comparing with a series of standard solutions of tetraethoxypropane.
NADH oxidase. Superoxide released from the fresh LV tissue homogenate was measured using discontinuous assay (23) . In brief, cytochrome c (100 M; Sigma) in Krebs-Ringer buffer was prepared in two separate wells. In one well, 100 g/ml superoxide dismutase (Sigma) were added. After 2 min at 37°C, 1-2 g/ml phorbol 12-myristate 13-acetate (PMA) from a stock of 1 mg/ml in DMSO were added. After 1 h of incubation, tissue extract was removed by centrifugation at 400 g for 5 min at 4°C. The amount of cytochrome c reduced in the supernatant was measured at 550 nm. The superoxide dismutase-containing samples were used as reference. NADH oxidase was estimated in micromoles per gram of tissue using an extinction coefficient of 19 cm Ϫ1 ⅐ mM Ϫ1 at 550 nm (23) .
Nitrate/nitrite. The concentrations of total NO in the LV tissue homogenate were estimated by measuring total nitrate/nitrite using a protocol kit (Cat. No. 22116) from Oxis Research (Portland, OR).
Nitrotyrosine. Nitrotyrosine in LV tissue homogenates was determined using mouse monoclonal anti-nitrotyrosine antibody (Upstate Biotechnology). Secondary anti-mouse alkaline phosphatase conjugate was used as a detection system. Fig. 1 . The levels of malondialdehyde (MDA), a marker of oxidative stress, were determined by measuring changes in the fluorescence at 560 nm, when excited at 525 nm, due to the reaction between tissue homogenate and added thiobarbituric acid (TBA). In this reaction, TBA reacts with MDA in the homogenate and emits fluorescence at 560 nm. The typical kinetic plots of initial reaction and fluorescence generated at 560-nm emission when excited at 525-nm excitation between TBA and left ventricular (LV) tissue homogenates prepared from arteriovenous (A-V) fistula and sham ϩ nicotinamide (Nic)-treated rats compared with buffer and reagents alone are shown in A. The same amount of total protein was added in each reaction mixture. B: 60 min after heating at 45°C, the fluorescence was recorded. On the basis of the standard curves generated for tetraethoxypropane (an acronym of MDA), the amounts of MDA were estimated. The amounts of MDA in tissue homogenates were normalized with total protein added into the reaction mixture and were measured as nanograms per milligram of protein. The following groups of rats are shown: sham operated (sham), sham ϩ Nic, A-V fistula, and A-V fistula ϩ Nic. *P ϭ 0.05; **P ϭ 0.005. Fig. 2 . LV tissue homogenates from sham ϩ Nic, A-V fistula, and A-V ϩ Nic groups were analyzed for nitric oxide (NO) concentrations according to the Griess reaction, in which NO is converted to NO3. The color generated at 540 nm was measured. The NO3 was used as the standard. The concentration of NO was normalized with the total tissue used for the extraction. *P ϭ 0.001; **P ϭ 0.005. 
Data are means Ϯ SE. Shown are the body weights, heart weights, left ventricle (LV), right ventricle (RV), and lung weights, mean arterial pressures (MAP), systolic and diastolic blood pressures (SBP and DBP, respectively), and heart rates (HR) of the control, sham-operated (sham), sham and nicotinamide (Nic)-treat (sham ϩ Nic), arteriovenous (A-V) fistula, and A-V fistula and Nic-treated (A-V fistula ϩ Nic) groups. End-diastolic pressure (EDP) was measured by a polyethylene-50 catheter in the LV. The levels of malondialdehyde (MDA) in LV tissue homogenates were measured by spectrofluorotometry. The levels of NADH oxidase were estimated by measuring superoxide generation. LV wall/LV diameter was significantly lower in the A-V fistula group than in any other group. Treatment with Nic tended to reverse the ratio, but insignificantly. * P Ͻ 0.05, A-V fistula group compared with sham group; † P Ͻ 0.05, A-V fistula ϩ Nic group compared with A-V fistula group.
To establish the specificity of nitrotyrosine, anti-nitrotyrosine-agarose conjugate (Upstate Biotechnology) was used to immunoprecipitate the total nitrotyrosine content in the sample before it was loaded onto the gel and/or blot.
MMP-2. There are currently 18 known MMPs. Interstitial fibrillar collagen is the primary collagen in the heart, and MMP-2 and -9 degrade interstitial collagen as well as elastin (1, 44) . To measure MMP-2 and -9 activity, zymography using 1% gelatin in SDS-PAGE as the impregnated substrate was performed on LV tissue homogenates prepared from the above groups of rats (55, 59) .
Collagen and its degradation. The mRNA for collagen was measured by Northern blots using a collagen cDNA probe as previously described (55) . The 18S RNA gene was used as a control. Because intrinsic activation of MMP cleaves fibrillar collagen to soluble 3/4 and 1/4 collagen fragments, therefore, the soluble collagen peptides were measured by immunoblot analysis using anti-collagen antibody in LV tissue homogenates. The bands below 100 kDa were identified as collagen cleavage products as previously described (55, 57) .
TIMP-4.
The levels of cardiospecific TIMP-4 mRNA were measured by Northern blot analysis using the cDNA probe isolated from RT-PCR. The primers for TIMP-4 that were used were as follows: sense, 5Ј -GTGACGAGAAGGAGGTGG-ATTCC-3Ј; and antisense, 5Ј -CTTGATGCAGGCAAAGAAC-TTGGC-3Ј (GenBank No. U76456). The isolated cDNA was radiolabeled by random primer labeling using [ 3) , and A-V fistula (lanes 4 and 5) groups. The specificity of anti-nitrotyrosine antibody was determined by immunoprecipitating the antigen in the LV tissue homogenates of A-V fistula rats (A-V-antbppt) before loading onto the gel (lane 6). B: bands labeled with nitrotyrosine were scanned and normalized with actin. *P ϭ 0.001; **P ϭ 0.03. (lanes 2 and 3) , and A-V fistula (lanes 4 and 5) groups were measured by gelatin-zymography. B: lytic bands at 72 and 92 kDa were scanned and normalized with actin. *P Ͻ 0.005; **P Ͻ 0.05. cytes were identified by labeling with phosphatase-conjugated myosin antibody (Sigma).
Endocardial endothelial function. The hearts were arrested in diastole by injecting 0.2 ml/100 g body wt of 20% KCl solution (intravenously). The LV and right ventricle (RV) were separated. LV wall thickness and diameter (in mm) were measured by a digital micrometer. The "deli"-shaped LV rings were mounted in a tissue myobath (31, 60) . One of the two mounted wires was connected to a force transducer.
The ring was stretched and brought to resting tension, at which time 20 mM CaCl 2 was added. At the maximum CaCl2 contraction, acetylcholine (endothelial dependent) or nitroprusside (endothelial independent) was added. The doseresponse curves were generated. The percent relaxation was 6 . Representative endothelial antigen staining of the heart: labeling of deparaffinized fixed tissue sections of the heart from A-V fistula rat (A) compared with the heart from a sham rat (B); ϫ20 magnification. C: histographic presentation of the percentage of endothelial cells. *P ϭ 0.001; **P ϭ 0.001. regarding endocardial endothelial function using deli-shaped LV rings has been established by measuring response to various cardiotonic agents (31, 60) .
Statistical analysis. Values are given as means Ϯ SE; n ϭ 6 rats/group. Differences between groups were evaluated by using ANOVA followed by the Bonferroni post hoc test (47) , focusing on the effects of volume overload (sham rats to A-V fistula rats) and treatment (A-V fistula ϩ Nic rats compared with A-V fistula rats). P Ͻ 0.05 was considered significant.
RESULTS
Hemodynamic parameters. The heart, LV, RV, and lung weights were increased in A-V fistula rats compared with sham controls. There was no significant change in the arterial pressure in the control and experimental groups. However, EDP was increased significantly in A-V fistula rats compared with sham. The levels of NADH oxidase activity were elevated in A-V fistula rats. Treatment with Nic regresses NADH oxidase and heart and lung weights and reduces LVEDP ( Table 1) .
Effect of Nic on the oxidative stress in the LV of A-V fistula rats. The results suggest a robust increase in MDA in the LV of A-V fistula rats compared with sham controls. Treatment with Nic decreases the levels of MDA, suggesting a role of NADH oxidase generated oxidative stress in chronic volume overload (Fig. 1) .
Effect of Nic on NO. The levels of NO were reduced in the LV of A-V fistula rats compared with sham controls. Nic treatment only partially restored the availability of NO in the LV of A-V fistula rats (Fig. 2) .
Effect of Nic on nitrotyrosine levels in the LV of A-V fistula rats. The levels of nitrotyrosine were increased twofold in A-V fistula rats compared with controls. Treatment with Nic decreased the formation of nitrotyrosine in the LV of A-V fistula rats (Fig. 3) .
Effect of Nic on MMP activity in the LV of A-V fistula rats. The results suggested a twofold increase (P ϭ 0.005) in 72-kDa MMP-2 and specific induction of 92-kDa MMP-9 in the LV of A-V fistula rats compared with controls. Treatment with Nic decreased MMP-2 activity to its basal level and inhibited completely the MMP-9 activity (Fig. 4) . These results elicit specific regulation of MMP at 92 kDa by oxidative stress in chronic volume overload.
Collagen and TIMP-4. The levels of collagen transcripts at 4.6 and 5.7 kb increased compared with control. Nic treatment blocked the collagen induction to the basal level in A-V fistula rats (Fig. 5) . The levels of TIMP-4 were significantly decreased in A-V fistula rats compared with sham controls. Treatment with Nic increased the level of TIMP-4 to that of the control (Fig. 5) .
Endocardial endothelial cells. The endothelial cell labeling surrounding the cardiomyocytes was optimal in the hearts of sham control rats. However, the labeling was significantly (n ϭ 6) decreased in the hearts of A-V fistula rats (Fig. 6 ). This suggests reduction in the endocardial endothelial cell density in A-V fistula hearts compared with sham controls.
Endocardial apoptosis. The endocardium of A-V fistula rats exhibited an increase in the number of TUNEL-positive cells compared with the sham controls. Treatment with Nic reduced the number of TUNEL-positive cells in A-V fistula rats (Fig. 7) . The staining of serial tissue sections for endothelial cell antigen suggests ϳ70% apoptotic nuclei from endothelial and ϳ25% from nonendothelial.
Endocardial dysfunction. The magnitude of relaxation and acetylcholine response was significantly depressed in the endocardium of A-V fistula rats compared with the sham controls. Treatment with Nic partially improved the acetylcholine response in A-V fistula rats (Fig. 8B) . The response to endothelial-independent nitroprusside was maintained in control and post-Nic treatment groups; however, not in A-V fistula rats (Fig. 8C) . These data may suggest impairment of endothelial as well as nonendothelial cells post-A-V fistula.
DISCUSSION
The results suggest that oxidative stress generated by chronic volume overload causes a decrease in NO concentration, generates nitrotyrosine, activates latent resident myocardial MMPs, and instigates apoptosis and hypertrophy in the LV of A-V fistula rats. Treatment with Nic inhibits poly(ADP-ribose)synthetase, an enzyme induced by oxidants and peroxynitrite, and causes apoptosis (7, 12) . Nic also inhibits NADH oxidase by competing for substrate binding (13) . Nic decreases oxidative stress and improves LVEDP by ameliorating the oxidative stress-mediated remodeling.
The degree of severity of chronic heart failure is correlated with the oxidative stress as measured by an increase in the production of MDA (14) . Our results suggest increased myocardial MDA in chronic volume overload (Fig. 1) . MDA is a product of cell membrane lipid peroxidation and, therefore, a direct marker of oxidative cell toxicity (3, 15) . The reduced endothelial cell density (Fig. 6 ) may lead to a decrease in endothelial NO concentration during chronic volume overload (49) . Our results demonstrate decreased NO in the LV of A-V fistula rats (Fig. 2) . One of the reasons of decreased levels of NO is that the NO in conjunction with thiols and oxygen radical generates nitrotyrosine (5, 20, 45) . A study comparing the role of peroxynitrite in blood versus crystalloid cardioplegia demonstrated increase nitrotyrosine in the LV with crystalloid cardioplegia and associated decrease in diastolic function (40) . Our results suggest increased nitrotyrosine contents (Fig. 3 ) in the LV with chronic volume overload.
It appears that the myocardium is well compensated at 4 wk of A-V fistula. However, it is known also that the myocardium continues to dilate and becomes thin. Brower et al. (8) demonstrated that pressure-volume curves continue to shift to the right even after 1 wk of A-V fistula. This can be explained by the following scenarios. The early MMP activity in the LV of volume overload by myocardial injury due to mitral valve regurgitation has been demonstrated (34). Janicki et al. (21) showed that the peak of MMP activity in the A-V fistula model occurring within the first week postoperatively is due, in part, to inflammatory infiltrate. The LV wall-to-LV diameter ratio was significantly lower in the A-V fistula group than in any other group (Table 1) . This may support a role of increased MMP activity (Fig. 4) and decreased TIMP-4 ( Fig. 5) in LV dilatation and wall thinning. Treatment with Nic tends to ameliorate the LV wall-to-LV diameter ratio, but insignificantly. The levels of collagen were increased in A-V fistula rats (Fig. 5) . Similar results were also obtained by Namba et al. (35) . Treatment with Nic reduces collagen expression to that of controls (Fig. 5) . This may argue that the effects of Nic on LVEDP, LV dilatation, and LV hypertrophy might just as well represent some systemic effect(s) on fluid retention and/or venomotor tone, which in turn could markedly reduce ventricular preload. In other words, the effects of Nic as an antioxidant may rather be primarily due to ventricular unloading. However, our ex vivo culture, load-free experiments suggest that Nic decreases MMP activity and nitrotyrosine, in part, by decreasing oxidative stress (30) . These results may suggest that decreasing oxidative stress may be an essential first step in amelioration of cardiac dysfunction in chronic volume overload.
The numbers of endothelial cells were decreased (Fig. 6 ) and the TUNEL-positive cells were increased in the endocardium of A-V fistula rats compared with the sham controls (Fig. 7) . The treatment with Nic decreased the number of apoptotic cells (Fig. 7) , although Nic inhibits oxidantmediated myocyte apoptosis by inhibiting poly(ADP-ribose) synthase (7, 12) . However, the decrease in the levels of MDA and nitrotyrosine contents by Nic does not necessarily suggest the improvement of NO-mediated cardiac relaxation; therefore, we measured acetylcholine and nitroprusside responses in cardiac rings (60) prepared from A-V fistula rats treated with and without Nic. Nitroprusside did not completely relax the heart from A-V fistula (Fig. 8C) , suggesting apoptosis of nonendothelial cells as well.
During increased oxidative tension in the LV, a number of events take place that lead to increased LVEDP. Our results suggest that the decreased NO concentration and increased MMP activity instigate apoptosis. This leads to endocardial endothelial dysfunction, hypertrophy, and an increase in LVEDP. Although collagen synthesis was increased in volume overload, the degradation of newly synthesized ultrastructural collagen was increased. The MMP-9 degrades collagen and elastin and leads to decreased collagen III-to-I and elastin-to-collagen ratios. This impairs synchronization of the myocytes and leads to increase end-diastolic volume and development of pressure. Treatment with Nic ameliorates the oxidative stress-mediated increase in LVEDP during chronic volume overload.
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